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A b s t r a c t
Background: Accumulated evidence suggests that macrophage migration inhibitory factor (MIF) plays a key role not only in 
acute and chronic inflammatory diseases but also in cardiovascular disease. The cardiac dysfunction is related to lipopolysac-
charide (LPS) in sepsis.
Aim: This study was designed to examine whether MIF mediates LPS-induced cardiac dysfunction and address the mechanisms. 
Methods: Echocardiography, immunohistochemical analysis, cell shortening/re-lengthening, and intracellular Ca2+ fluores-
cence evaluation were performed in whole hearts and isolated cardiomyocytes from C57 and MIF knockout mice treated 
with or without LPS. Reactive oxygen species and protein carbonyl formation were measured. Activation of mitogen-activated 
protein kinases and endoplasmic reticulum stress markers were evaluated using Western blot analysis. Human umbilical vein 
endothelial cells (HUVECs) were transfected with lentiviruses carrying short hairpin RNA (shRNA) to inhibit MIF. 
Results: Echocardiography revealed that cardiac function was impaired and macrophage infiltration was increased in LPS-treated 
C57 mice. Peak shortening and maximal velocity of shortening/re-lengthening were significantly reduced and the duration of 
re-lengthening was prolonged in LPS-treated C57 mice. Reactive oxygen species and protein carbonyl levels were increased 
in LPS-treated C57 mice. These dysfunctional changes were attenuated in MIF knockout mice that were challenged with LPS. 
Western blot analysis revealed that activated p-JNK, p-ERK, and endoplasmic reticulum stress protein marker expression was 
decreased in LPS-treated MIF knockout mice. p-ERK and p-JNK levels were knocked down in MIF shRNA-transfected HUVECs. 
Conclusions: The data collectively suggest that MIF mediates LPS-induced cardiac dysfunction in murine cardiomyocytes, 
which was attenuated by MIF knockout, and the therapeutic option with regard to MIF may aid the management of cardiac 
dysfunction in sepsis.
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INTRODUCTION 
Sepsis is one of the main causes of death among hospital-
ised patients, especially those in the intensive care unit. It 
is a major medical problem that often results in multiple 
organ failure. Sepsis is known to be triggered by the effects 
of one or more components of the invading microorgan-
isms, including lipopolysaccharide (LPS) endotoxin from 
gram-negative bacteria, which results in systemic disruption 
of the normal inflammatory response [1, 2]. Heart failure is 
the most devastating organ dysfunction arising from septic 
shock. The relationship between myocardial dysfunction and 
cardiovascular failure in human and experimental septic shock 
has become clearer. A series of clinical cardiac manifestations 
are commonly observed in septic patients, including biven-
tricular dilatation, decreased ejection fraction, and decreased 
myocardial contractility. 
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Many studies have shown the activation of multiple stress sig-
nalling cascades in sepsis. Inducible nitric oxide synthase (iNOS), 
oxidative stress, and mitogen-activated protein kinase (MAPK) are 
believed to play a pivotal role in the pathogenesis of septic cardiac 
dysfunction [3–5]. Reactive oxygen species (ROS) are formed as 
a natural by-product of the normal metabolism of oxygen and 
play important roles in cell signalling and homeostasis. Extracel-
lular signal-related kinase (ERK) and c-Jun N-terminal kinase 
(JNK) are major MAPK family members. A variety of stimuli can 
lead to the accumulation of unfolded and misfolded proteins in 
the endoplasmic reticulum (ER). The unfolded protein response 
(UPR) initiates ER stress when ER transmembrane sensors detect 
the accumulation of unfolded proteins.
Macrophage migration inhibitory factor (MIF) was 
originally discovered as a lymphokine derived from activated 
T cells. MIF inhibits the random migration of macrophages 
in vitro and regulates T-cell activation as well as proliferation. 
Proinflammatory actions of MIF have been reported in various 
inflammatory diseases, such as sepsis, rheumatoid arthritis, 
and atherosclerosis [6–8]. Ha et al. [9] treated caecal ligation 
and puncture-induced septic mice with glucan phosphate, 
which has been reported to modulate innate immunity and 
proinflammatory signalling in sepsis, and showed that cardiac 
function was preserved and MIF expression was attenuated. 
Furthermore, patients with rapidly fatal outcomes exhib-
ited simultaneously high MIF and interleukin (IL)-10 levels 
in the early phase of severe sepsis [10]. Nonetheless, little 
information is available regarding the role of MIF in cardiac 
dysfunction due to sepsis. This study aimed to verify the 
contribution of MIF to myocardial dysfunction and address 
the possible mechanisms.
METHODS
Experimental animals and LPS treatment. All animal proce-
dures were approved by the Animal Care and Use Committee 
at the Shandong Provincial Hospital affiliated to Shandong 
University (Shandong, China). Age-matched male C57 and 
MIF knockout mice (MIFKO) on a C57 background were 
used. There were eight mice in each experimental group. All 
animals were kept in our institutional animal facility with free 
access to laboratory chow and tap water. On the day of experi-
mentation, both C57 and MIFKO mice were intraperitoneally 
injected with 4 mg/kg Escherichia Coli LPS (Sigma-Aldrich, St. 
Louis, MO, USA) dissolved in sterile saline or an equivalent 
volume of pathogen-free saline (for control groups). The dos-
age for LPS injection was chosen based on previous studies 
to induce overt myocardial dysfunction without significant 
mortality [11]. Four hours after LPS challenge, mice were 
anaesthetised using ketamine and xylazine (3:5, 1.32 mg/kg), 
and were sacrificed by cervical dislocation. 
Cell culture and gene interference. Human umbilical 
vein endothelial cells (HUVECs) were purchased from the 
ATCC (CRL-1730) and cultured in Dulbecco’s Modified Eagle’s 
Medium containing 10% foetal bovine serum, 100 U/mL peni-
cillin, 100 U/mL streptomycin, and L-glutamine at 37oC in 5% 
CO2. shRNA was synthesised by Genechem (Shanghai, China). 
HUVECs were transfected with lentiviruses carrying shRNAs 
against MIF. To achieve stable interference, duplex RNAs 
targeting MIF (sense strand: CCAGTACATCGCGGTGCACGT) 
and control RNAs (sense strand: TTCTCCGAACGTGTCACGT) 
were inserted into the GV115 vector according to the manu-
facturer’s instructions. The control cells and knockdown cells 
were treated with 100 ng/mL LPS for the indicated times.
Histological and immunohistochemical analysis. 
Hearts from mice were collected at the indicated times, 
fixed overnight in 10% formalin, and embedded in paraffin. 
Serial 5-μm heart sections from each group were analysed. 
Samples were stained with haematoxylin and eosin for routine 
histologic examination. The histological sections were stained 
with primary antibodies against a-2-macroglobulin (Mac-2) 
(1:200, Abcam, Cambridge, MA, USA) at 4°C overnight. The 
bound antibodies were labelled using a secondary antibody 
(VECTOR Laboratories, Inc., Burlingame, CA, USA). Images 
were analysed with NIH ImageJ software. The number of 
Mac-2-positive macrophages was counted blindly and ex-
pressed as a percentage of the total number of cardiomyocytes 
in five sequentially cut 5-μm sections of each heart.
Echocardiographic examination. Transthoracic echo-
cardiography was performed on animals using a Sequoia 
512 device with a GE-i13L probe before they were sacri-
ficed. Isoflurane (1.5%–2.0%) was used for anaesthesia. The 
M-mode echocardiogram was obtained in the short-axis view 
of the left ventricle at the level of the chordae tendineae. Left 
ventricular end-diastolic dimension (LVEDD), left ventricular 
end-systolic dimension (LVESD), and left ventricular diastolic 
interventricular septal thickness were measured. Left ventricu-
lar ejection fraction (LVEF) was also calculated from M-mode 
echocardiograms. Data from three to five consecutive cardiac 
cycles were analysed and averaged.
Isolation of murine cardiomyocytes. Mice were given 
100 units of heparin intraperitoneally (Sagent Pharmaceu-
ticals, Schaumburg, IL, USA) for anticoagulation. The heart 
was excised and fastened onto a heart perfusion apparatus 
(Radnoti, Monrovia, CA, USA), and perfusion was initiated 
in the Langendorff system. Hearts were perfused at 37°C 
with a Ca2+-free Krebs-Henseleit-based buffer (pH 7.3). After 
a few minutes of stabilisation, the heart was digested with the 
same perfusion buffer containing 0.067 mg/mL of Liberase 
Blendzyme 4 (Roche, Indianapolis, IN, USA). After perfusion, 
the left ventricles were removed and minced to disperse car-
diomyocytes in Ca2+-free KHB buffer. Extracellular Ca2+ was 
incrementally added to achieve a concentration of 1.25 mM. 
Only rod-shaped myocytes with clear edges were selected 
for mechanical and intracellular Ca2+ transient studies. Cells 
were used for functional or biochemical assessment within 
6 h of isolation. 
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Cell shortening/re-lengthening. IonOptix SoftEdge soft-
ware (Westwood, MA, USA) was used to capture changes in 
cell length during shortening and re-lengthening. Cell short-
ening and re-lengthening were assessed using the following 
indices: peak shortening (PS) — indicative of the maximal 
amplitude a cell can shorten during contraction; maximal 
velocities of cell shortening/re-lengthening (± dL/dt) — in-
dicative of peak ventricular contractility; time-to-PS (TPS) 
— indicative of systolic duration; time-to-90% re-lengthening 
(TR90) — indicative of diastolic duration (90% rather than 
100% re-lengthening was used to avoid the noisy signal at 
the baseline concentration); and maximal velocities of short-
ening/re-lengthening — indicative of maximal velocities of 
ventricular pressure increases/decreases [4]. 
Intracellular Ca2+ fluorescence measurement. Intracel-
lular Ca2+ was measured using a dual-excitation, single-emis-
sion photomultiplier system (IonOptix Corporation, Milton, 
MA, USA). Cardiomyocytes were loaded with Fura-2-AM 
(2 μM) and were exposed to light emitted by a 75-W halogen 
lamp through either a 340-nm or 380-nm filter while being 
stimulated to contract at a frequency of 0.5 Hz. Fluorescence 
emissions were then detected. The fluorescence decay time 
was assessed as an indication of intracellular Ca2+ clearing. 
Both single and bi-exponential curve fit programmes were 
applied to calculate the intracellular Ca2+ decay constant [4].
Generation of intracellular ROS. The OxiSelect™ ROS 
Assay Kit (Cell Biolabs, CA, USA) is a cell-based assay that 
measures ROS activity. The assay employs the cell-permeable 
fluorogenic probe DCFH-DA, which diffuses into cells and 
is deacetylated by cellular esterases into a non-fluorescent 
form. In the presence of ROS, DCFH is rapidly oxidised to 
highly fluorescent DCF. The fluorescence signal was detected 
on a standard fluorometric plate reader. 
Protein carbonyl assay. The protein carbonyl content 
in tissue lysate was determined using a Protein Carbonyl 
Colorimetric Assay Kit (Cell Biolabs, CA, USA) according to 
the manufacturer’s instructions.
Western blot analysis. Cardiac tissue was sonicated in 
lysis buffer and centrifuged at 12,000 g for 10 min. Equal 
amounts (20 μg) of protein and a pre-stained molecular weight 
marker were separated using 7% to 15% SDS-polyacrylamide 
gels in a minigel apparatus (Mini-PROTEAN II, Bio-Rad, Hercules, 
CA, USA) and were then transferred to nitrocellulose membranes 
(0.2-μm pore size, Bio-Rad). Membranes were blocked for 1 h in 
5% non-fat milk before being rinsed in Tris Buffered Saline-Tween. 
The membranes were incubated overnight at 4°C with anti-ERK, 
anti-phospho-ERK (p-ERK), anti-JNK, anti-phospho-JNK (p-JNK), 
anti-IRE1a, anti-eIF2a, anti-Grp78, and anti-Gadd153 antibod-
ies. Anti-ERK and anti-pERK antibodies were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other an-
tibodies were acquired from Cell Signaling Technology (Beverly, 
MA, USA). After incubation with the primary antibodies, blots 
were incubated with horseradish peroxidase (HRP)-coupled 
anti-rabbit secondary antibodies (Cell Signaling, Beverly, MA, 
USA). Films were scanned with the Bio-Rad GS-700 scanner, 
and the relative density of the bands on the film was determined 
using ImageJ software.
Statistical analysis
Data are presented as the mean ± standard error of the mean 
(SEM) and analysed using GraphPad Prism 7.0 (La Jolla, CA, 
USA) statistical analysis software. Differences were assessed us-
ing analysis of variance (ANOVA) followed by Tukey’s post hoc 
test. A p value < 0.05 was considered statistically significant.
RESULTS
Heart weight and echocardiographic properties  
of C57 and MIFKO mice treated with LPS
Lipopolysaccharide treatment did not affect heart weights in 
either C57 or MIFKO mice. Knockout of MIF did not affect 
heart rate, interventricular septal thickness, LVEDD, LVESD, or 
LVEF. LPS significantly increased LVESD and reduced ejection 
fraction in LPS-treated C57 mouse hearts, the effect of which 
was attenuated or ablated by MIF knockout (Table 1, Fig. 1).
Inflammation in LPS-treated mice
The effect of MIF knockout on cardiac inflammation was 
assessed by immunohistochemical staining with an antibody 
Table 1. Heart weight and echocardiographic parameters of lipopolysaccharide (LPS)-treated C57 and migration inhibitory factor 
knockout (MIFKO) mice
Parameter C57 C57-LPS MIFKO MIFKO-LPS
Heart weight [mg] 115 ± 9 123 ± 18 119 ± 13 118 ± 10
Heart rate [bpm] 422 ± 39 441 ± 21 449 ± 30 430 ± 26
IVS thickness [mm] 0.90 ± 0.03 0.88 ± 0.05 0.87 ± 0.08 0.79 ± 0.06
LVEDD [mm] 2.27 ± 0.14 2.40 ± 0.21 2.16 ± 0.28 2.29 ± 0.19
LVESD [mm] 1.11 ± 0.12 1.79 ± 0.13* 1.19 ± 0.11 1.39 ± 0.15
Ejection fraction [%] 71.5 ± 5.2 47.7 ± 5.8* 68.7 ± 7.1 58.8 ± 4.9#
Data are shown as mean ± standard error of the mean (SEM); IVS — interventricular septal; LVEDD — left ventricular end-diastolic dimension; 
LVESD — left ventricular end-systolic dimension; n = 4–6 mice per group. *p < 0.05 vs. the C57 group; #p < 0.05 vs. the C57-LPS group
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against Mac-2 (a macrophage marker). Macrophage infiltration 
was unchanged in MIF knockout mice. More inflammatory 
cells infiltrated the hearts of LPS-treated C57 mice compared 
to the hearts of their littermates. In LPS-treated MIFKO mice, 
Mac-2-positive cell number was decreased compared with 
LPS-treated C57 mice (Fig. 2). 
Figure 1. Representative echocardiographic recordings from four mouse groups. A. The C57 group; B. The C57-LPS group;  





Figure 2. Representative images of haematoxylin and eosin staining and Mac-2 staining for the evaluation of inflammation.  
A, E. The C57 group; B, F. The C57-LPS group; C, G. The MIFKO group; D, H. The MIFKO-LPS group. Data are shown as mean  
± standard error of the mean (SEM); n = 4 samples per group; *p < 0.05 vs. the C57 group; #p < 0.05 vs. the C57-LPS group
A B C D
E F G H
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Mechanical and intracellular Ca2+ properties  
of murine cardiomyocytes 
Mechanical recording revealed that the resting cell length 
was similar in cardiomyocytes from both C57 and MIFKO 
mouse hearts. However, cardiomyocytes from the LPS-treated 
C57 mice displayed significantly reduced PS and ± dL/dt 
associated with prolonged TR90 and normal TPS. Interestingly, 
MIF knockout effectively protected cardiomyocytes from 
LPS-induced mechanical dysfunction without eliciting any 
overt side effects (Fig. 3), which indicated that MIFKO may 
play a protective role against LPS-induced cardiac dysfunc-
tion. To explore the potential mechanisms involved in the 
MIFKO-elicited protection against LPS-induced cardiomyocyte 
contractile defects, intracellular Ca2+ homeostasis was evalu-
ated using the fluorescent dye fura-2. The results showed that 
a reduced intracellular Ca2+ clearance rate (i.e. increased decay 
Figure 3. Cardiomyocyte contractile properties in C57 and MIFKO mice treated with or without lipopolysaccharide (LPS) 
(4 mg/kg, i.p.). A. Resting cell length; B. Peak shortening (PS, normalised to cell length); C. Maximal velocity of shortening 
(+ dL/dt); D. Maximal velocity of re-lengthening (– dL/dt); E. Time to PS (TPS); F. Time to 90% re-lengthening (TR90). Data are 
shown as mean ± standard error of the mean (SEM); n = 60 cells from three mice per group. *p < 0.05 vs. the C57 group; 
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time) (both single- and bi-exponential decay) was associated 
with unchanged resting and electrically stimulated increases 
in intracellular Ca2+ levels in the cardiomyocytes. Intriguingly, 
cardiomyocytes from LPS-treated C57 mice exhibited slower 
Ca2+ clearing than cardiomyocytes from LPS-treated MIFKO 
(Fig. 4). Together, these data suggest a beneficial role for MIF 
inhibition in LPS-associated cardiac dysfunction.
Effect of LPS on ROS generation  
and protein carbonyl formation
As shown in Figure 5A, ROS production was enhanced in 
myocytes from LPS (20 μg/mL)-treated mice. Interestingly, 
myocytes obtained from MIFKO mice displayed significantly 
reduced ROS generation in response to LPS exposure com-
pared with those from LPS-treated C57 mice, suggesting that 
MIFKO partly antagonised LPS-induced ROS generation. 
These data indicate that the MIF inhibition may eliminate 
LPS-induced cardiac mechanical dysfunction via a mechanism 
related to reduction in ROS generation. The results shown 
in Figure 5B indicate that protein carbonyl formation was 
enhanced in hearts from LPS-treated C57 mice compared 
with hearts from MIFKO mice. Although MIF knockout itself 
had little effect on cardiac protein carbonyl formation, it 
partially reversed LPS-induced protein carbonyl formation, 
suggesting a protecting effect of MIF deficiency against cardiac 
protein damage.
Effect of MIFKO on the LPS-induced  
activation of stress signalling
Lipopolysaccharide challenge is usually associated with acti-
vation of stress signalling. The results shown in Figure 6A, B 
demonstrate the activation of p-JNK and p-ERK in the myo-
cardium following LPS challenge. This effect was attenuated 
in MIFKO mice. It is interesting that in MIFKO mice without 
LPS challenge the ratios of p-ERK/ERK and p-JNK/JNK were 
increased, whereas protein expression of non-phosphorylated 
ERK and JNK was not different between C57 and MIFKO mice. 
To further detect the effect of MIF knockdown on ERK and 
Figure 4. Intracellular Ca2+ properties in cardiomyocytes from C57 and MIFKO mice treated with or without lipopolysaccharide 
(LPS) (4 mg/kg, i.p.). A. Resting intracellular Ca2+; B. Electrically stimulated rise in intracellular Ca2+; C, D. Single- and bi-exponen-
tial intracellular Ca2+ decay rate. Data are shown as mean ± standard error of the mean (SEM); n = 60 cells from three mice per 
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Figure 5. A. Intracellular reactive oxygen species measurement by dichlorofluorescein fluorescence detection; B. Protein damage  
evaluated by protein carbonyl formation. Data are shown as mean ± standard error of the mean (SEM); n = 4 samples per group. 
*p < 0.05 vs. the C57 group; #p < 0.05 vs. the C57-LPS group
Figure 6. Western blot analysis exhibiting phosphorylation of extracellular signal-related kinase (ERK) and c-Jun N-terminal kinase 
(JNK) in the myocardium of C57 and MIFKO mice treated with or without lipopolysaccharide (LPS) (4 mg/kg. i.p.). A. The pJNK-
-to-JNK ratio; B. The pERK-to-ERK ratio. Data are shown as mean ± standard error of the mean (SEM); n = 4 samples per group. 
*p < 0.05 vs. the C57 group; #p < 0.05 vs. the C57-LPS group. The effect of migration inhibitory factor (MIF) knockdown on 
related signal transduction pathways; C. Human umbilical vein endothelial cells (HUVECs) were transfected with lentiviruses 
carrying MIF shRNA at different multiplicities of infection (MOIs) for 24 h. MIF, p-ERK, p-JNK, and actin levels were evaluated by 
Western blot; D. The control cells and knockdown cells were treated with 100 ng/mL LPS for 0, 4, 12, and 24 h. The effect of LPS 
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JNK, HUVECs were transfected with lentiviruses carrying MIF 
shRNA at different multiplicities of infection for 24 h. Figure 6C 
shows that p-ERK level was decreased by MIF shRNA trans-
fection. However, p-JNK level was increased by MIF shRNA 
transfection. Control cells and MIF knockdown cells were 
treated with 100 ng/mL LPS for 0, 4, 12, and 24 h. LPS in-
duced the expressions of MIF, p-ERK, and p-JNK, which were 
attenuated in MIF knockdown cells (Fig. 6D). p-JNK level at 
24 h was increased by LPS treatment both in control cells and 
MIF knockdown cells comparing with its level at 0 h. This 
result was in accordance with the variation trend of p-JNK 
expression in Figure 6C.
Effect of MIFKO on LPS-induced ER stress 
To further understand the molecular mechanism underlying 
the beneficial effects of MIFKO in the heart during LPS chal-
lenge, ER stress proteins were assessed by immunoblotting. 
The data clearly demonstrate that LPS markedly stimulated 
ER stress markers IRE1a, Gadd153, Grp78, and eIF2a in 
LPS-treated C57 mice (Fig. 7), the effect of which was oblit-
erated by MIFKO. However, the baseline expression of IRE1a, 
Gadd153, Grp78, and eIF2a was unaffected by MIF knockout.
DISCUSSION
Our study revealed that cardiac knockout of MIF rescued 
LPS-induced cardiac contractile and intracellular Ca2+ dys-
function. Reactive oxygen species and protein carbonyl levels 
were decreased in LPS-treated MIFKO mice. The MIFKO-in-
duced cardioprotection against sepsis may be attributed to 
the alleviation of ER stress in MIFKO mice. Furthermore, in 
MIFKO mice, the LPS-induced activation of JNK and ERK 
signalling molecules was decreased. More inflammatory cells 
infiltrated the hearts of LPS-treated C57 mice compared to 
those of LPS-treated MIFKO mice. Examination of mechanical 
properties revealed reduced PS, ± dL/dt, as well as prolonged 
relaxation duration (TR90) in septic C57 cardiomyocytes. LPS 
treatment significantly attenuated cardiomyocyte contrac-
tion and the electrically stimulated rise in intracellular Ca2+, 
suggesting a role for intracellular Ca2+ in endotoxin-induced 
cardiomyocyte dysfunction. Collectively, these findings sug-
gest that MIF inhibition has a direct cardioprotective effect 
rather than an indirect effect, from the modulation of the 
LPS-induced endotoxin response. Data also showed that MIF 
inhibition itself did not significantly affect cardiac contractile 
function without the presence of endotoxin. The protec-
tive effect of MIF inhibition against LPS-induced cardiac 
dysfunction and ER stress implies its therapeutic potential in 
the clinic. Therefore, MIF inhibition may be used to manage 
cardiovascular complications in sepsis. 
Migration inhibitory factor has been recognised as a po-
tent proinflammatory mediator in the progression of systemic 
inflammation. This cytokine appears to be a critical regulator 
of the inflammatory pathways [12]. An abundance of clinical 
and experimental evidence has shown cardiac contractile 
dysfunction in sepsis. Animal studies have shown that ad-
ministration of neutralising anti-MIF antibodies or deletion 
of the MIF gene protected mice from lethality induced by 
endotoxaemia or sepsis. Dhanantwari et al. [13] used cul-
tured cardiomyocytes to determine whether MIF-induced 
contractile dysfunction was mediated in part by myocyte 
apoptosis and to identify MIF-activated intracellular signalling 
pathways in this process. MIF stimulated the rapid, transient 
phosphorylation of the stress kinases, p38 MAPK and JNK. 
This effect was attenuated by inactivation of MIF with the 
chemical inhibitor ISO-1. However, Xu et al. [14] showed that 
doxorubicin-induced cardiac remodelling and dysfunction 
were accentuated by genetic MIF deficiency, as shown by 
more pronounced adverse effects on mortality, and myocardial 
geometry and function. Many studies have shown the pros-
pects of using anti-MIF antibodies in basic research and clinical 
applications. The inhibition of MIF may cause the reduction 
of the severity of age-related osteoarthritis in mice [15]. 
Figure 7. Western blot analysis of the expression of the endo- 
plasmic reticulum (ER) stress markers IRE1a, Gadd153, Grp78, 
and eIF2a in the myocardium from C57 and MIFKO mice 
treated with or without lipopolysaccharide (LPS) (4 mg/kg, i.p.). 
A. Representative gel blots depicting IRE1a, Gadd153, Grp78, 
and eIF2a proteins expression as detected using specific 
antibodies; B. Pooled data of IRE1a, Gadd153, Grp78, and 
eIF2a proteins (normalised to GAPDH). Data are shown as 
mean ± standard error of the mean (SEM); n = 4 samples  
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Targeted deletion of MIF gene delays the development of 
chronic lymphocytic leukaemia and prolongs survival in 
mice [16].
Mitogen-activated protein kinase pathways can be 
activated by cellular stress signals, such as inflammatory 
cytokines. ERK, JNK, and p38 are major MAPK family mem-
bers and play a vital role in myocardial injury by promoting 
cardiomyocyte apoptosis and inflammation [17]. Our results 
demonstrated that MIFKO ablated the sepsis-elicited activa-
tion of ERK and JNK. Lin et al. [18] showed that MIF was 
produced in the lungs and released into circulation during ex-
perimental sepsis and that this release was temporarily related 
to activation of the stress-related MAPK signalling pathways in 
the myocardium. The data from Aoki et al. [19] showed that 
MIF activated JNK and p38, although JNK has been shown 
to be a direct activator of mitochondrial death machinery in 
cardiomyocytes. Recently, a study showed that compared to 
WT mice, MIFKO mice had a significantly lower incidence of 
post-MI cardiac rupture and exhibited amelioration of cardiac 
remodelling. These effects were associated with suppressed 
myocardial leukocyte infiltration, inflammatory mediator 
expression, and MMP-2, MMP-9, p38, and JNK activity [20]. 
The endoplasmic reticulum is an extensive intracellular 
membranous network involved in Ca2+ storage, Ca2+ signal-
ling, glycosylation, and trafficking of membrane and secretory 
proteins. Our results revealed overt ER stress in the myocardium 
following LPS-induced endotoxaemia. ER stress has been shown 
to contribute to neurodegenerative disorders and ischaemia 
reperfusion-induced cardiac damage [21, 22]. Our data re-
vealed upregulated expression of the ER chaperone Grp78, 
which directly interacts with all three ER stress sensors, eIF2a, 
Gadd153, and IRE1a in sepsis. Upregulation of Grp78 is 
pivotal for cell survival because it facilitates the folding and 
assembly of ER proteins and prevents them from aggregating 
during ER stress. We observed that the LPS-induced increase 
of Grp78, Gadd153, eIF2a, and IRE1a was attenuated in 
MIFKO mice, which suggests an important role for MIF in ER 
stress induction in the heart.
Three limitations of this study should be mentioned. First, 
the dose of LPS used to induce sepsis in mice is much higher 
than that observed in humans. Additionally, different genes are 
expressed in sepsis in mice and humans. The innate immune 
system can be activated in sepsis, and it can exert both positive 
and negative impacts upon the organism. Second, long-term 
observations are required to confirm whether the response 
of ER stress is a “double-edged sword” for cardiac function. 
Third, specimens and data should be collected from septic 
patients to observe the relationship between cardiac function 
and sepsis in the clinic.
In conclusion, our study revealed that the cardiac knock-
out of MIF rescued LPS-induced cardiomyocyte contractile 
dysfunction and intracellular Ca2+ mishandling, potentially 
by alleviating stress signalling activation. The sequential 
relationship between MIF and ER stress in altering cardiac 
function remains to be determined. Whether ER stress is 
adaptive or maladaptive in the context of sepsis also remains 
to be determined. These approaches are essential for the 
potential application of anti-MIF in the clinical management 
of endotoxin-associated cardiac dysfunction.
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